Watch note
CRSP: watch rule from Low-volatility and portfolio-balance desk
Compares risky ideas against defensive assets, bonds, and volatility. The desk is watching whether CRISPR Therapeutics can hold near $249.50. A reclaim above $253.99 would turn this into a possible entry note.
$249.50Watch
$253.99Posting trigger
Watch onlyStatus